Home · Stock · EW

EW Edwards Lifesciences Corp

Which ETFs hold EW? Edwards Lifesciences Corp is held by 2 funds tracked by ETFpeek.

Held by 2 funds todayData as of 31 Aug 2026
HealthcareMedical Devices
$84.24
+13.9% 1y
$72.3052-week range$96.29
Market cap
$49.1B
P/E
50.1
3-month
-8.6%
CEO
Mr. Bernard J. Zovighian
Revenue · last 4 qtrs (+13.6% YoY)

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Provider

Currently Held By

VANGUARD
VOO
Weight in fund0.08%
Shares held15,294,692
Market value$1.39B
View fund →
SMARTSHARES
USF
Smart US 500 ETF
via VOO
Weight in fund0.08%
Shares held—
Market value$990K NZD
View fund →
Not held by the selected provider.
last 90 days
No insider activity recorded in the last 90 days.
0 trades
DateFundDirectionShares Changed% Δ ETF i% Δ Position i
No trades recorded yet.
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

More stocks in these funds